Touchstone
Last syncNov 1, 2026, 6:55 PM ET

TFX

Teleflex Inc Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$139.77Close $6.7BMarket cap $99.54 – $142.0552-week range Nov 5, 2026Next report · before the open

Highlights

Strengths

  • Near its high 2% below its 52-week high

Cautions

  • Trend not confirmed 7 of 8 conditions · RS under 70
  • Distribution down-day volume 1.5× up-day volume over 50 sessions
  • Earnings shrinking EPS −17% year on year
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 2%
1wk up 2.6% price change
1mo up 11.8% price change
12-month return up 13% market up 11% · its own down 1%
F-score 4 / 9 Weak
Altman Z 2.24 Moderate risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 2.2× price / book
Earnings yield up 1.3% EBIT / enterprise value
Cheaper than 41% of the market · around average
Revenue growth up 17% year on year
EPS growth down 17% latest quarter · +91 pts
Sales growth up 29% latest quarter · -3 pts
ROE down 24% return on equity
Free cash margin 0% $1.4M FCF
D/E 0.81 long-term debt / equity
Net debt / EBITDA 7.3×
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • profitability slipped from last year
  • took on more long-term debt
  • issued more shares
  • gross margin narrowed
  • generating cash from operations
  • profits backed by cash
  • short-term liquidity improved
  • assets working harder

Repair signals

  • Revenue reaccelerating (-1% then +17%)

Trade setup

ATR% 2.7% $3.75 a day · 2×ATR $132.28
RS 66 / 99 vs the universe
Trend 7 / 8 RS under 70
Relative volume 1.2× vs 50-day average
Up/down volume 0.66 50 sessions
Implied move — no option chain · report Nov 5, 2026
Trend template · 7 of 8
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Heavily indebted Net debt is 7.3 times EBITDA — roughly 7 years of earnings before interest, tax and depreciation to repay borrowings in full.
  • Gross margin narrowing Gross margin fell from 61.0% to 56.2%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Aug 6, 2026
Results reaction Aug 6, 2026-2% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.0B +17% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $2.5B FY2021 · $2.8B FY2022 · $2.8B FY2023 · $1.7B FY2024 · $1.7B FY2025 · $2.0B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$905.6M down to a loss
-$1B $0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $335.3M FY2021 · $485.4M FY2022 · $363.1M FY2023 · $357.6M FY2024 · $70.2M FY2025 · -$905.6M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $1.4M -99% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $346.4M FY2021 · $580.5M FY2022 · $263.6M FY2023 · $159.7M FY2024 · $211.4M FY2025 · $1.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 56%
  • Net -45%
  • Free cash 0%
-50% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 52% · Net 13% · Free cash 14% FY2021 · Gross 55% · Net 17% · Free cash 21% FY2022 · Gross 55% · Net 13% · Free cash 9% FY2023 · Gross 61% · Net 21% · Free cash 9% FY2024 · Gross 61% · Net 4% · Free cash 12% FY2025 · Gross 56% · Net -45% · Free cash 0%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $2.2B net debt
  • Cash
  • Long-term debt
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $375.9M · Long-term debt $2.4B FY2021 · Cash $445.1M · Long-term debt $1.7B FY2022 · Cash $292.0M · Long-term debt $1.6B FY2023 · Cash $222.8M · Long-term debt $1.7B FY2024 · Cash $247.9M · Long-term debt $1.6B FY2025 · Cash $378.6M · Long-term debt $2.5B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 48.20m +0.8% since FY2020
48.20m 47.81m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 47.81m FY2021 · 47.93m FY2022 · 47.96m FY2023 · 48.05m FY2024 · 48.05m FY2025 · 48.20m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $2.5B $2.8B $2.8B $1.7B $1.7B $2.0B
Gross margin 52% 55% 55% 61% 61% 56%
Operating income $423.1M $628.1M $499.7M $258.7M $103.7M $118.4M
Net income $335.3M $485.4M $363.1M $357.6M $70.2M -$905.6M
Net margin 13% 17% 13% 21% 4% -45%
Earnings per share $7.09 $10.23 $7.68 $7.56 $1.49 -$20.25
Free cash flow $346.4M $580.5M $263.6M $159.7M $211.4M $1.4M
Free cash margin 14% 21% 9% 9% 12% 0%
Cash $375.9M $445.1M $292.0M $222.8M $247.9M $378.6M
Long-term debt $2.4B $1.7B $1.6B $1.7B $1.6B $2.5B
Shareholders' equity $3.3B $3.8B $4.0B $4.4B $4.3B $3.1B
Shares outstanding 47.81m 47.93m 47.96m 48.05m 48.05m 48.20m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 27, 2026 Annual ↗ Dec 31, 2025 58d
Nov 6, 2025 Quarterly ↗ Sep 28, 2025 39d
Jul 31, 2025 Quarterly ↗ Jun 29, 2025 32d
May 1, 2025 Quarterly ↗ Mar 30, 2025 32d
Feb 28, 2025 Annual ↗ Dec 31, 2024 59d
Oct 31, 2024 Quarterly ↗ Sep 29, 2024 32d
Aug 2, 2024 Quarterly ↗ Jun 30, 2024 33d
May 3, 2024 Quarterly ↗ Mar 31, 2024 33d
Feb 23, 2024 Annual ↗ Dec 31, 2023 54d
Nov 3, 2023 Quarterly ↗ Oct 1, 2023 33d

Current reports

FiledDisclosed
Sep 9, 2026 Director or officer change · Regulation FD ↗
Aug 7, 2026 Other events ↗
Aug 6, 2026 Results · Regulation FD ↗
Aug 3, 2026 Acquisition or disposal · Regulation FD ↗
Jun 15, 2026 Material agreement · New obligation ↗
Jun 9, 2026 Director or officer change ↗
Jun 2, 2026 Other events ↗
Jun 1, 2026 Regulation FD · Other events ↗
May 27, 2026 Material agreement · New obligation ↗
May 20, 2026 Shareholder vote ↗
May 7, 2026 Results · Regulation FD ↗
Apr 30, 2026 Director or officer change ↗